Weight loss and GLP-1
Weight Loss & GLP-1 Treatment Referrals
Miracle Leaf® does not evaluate patients or prescribe. We refer interested patients to Heally, whose licensed providers review your health history and decide what is appropriate.
Weight loss and GLP-1 telehealth connects patients considering treatments like semaglutide and tirzepatide with a licensed medical evaluation from home, rather than requiring an in-person weight loss clinic visit for every step of the process. Miracle Leaf does not perform this evaluation itself. We refer interested patients to Heally, an independent telehealth platform whose own licensed providers review your health history and determine whether a treatment is appropriate for you before anything is prescribed. The GLP-1 medication class includes both branded products that carry a specific FDA weight management approval and options that a provider may prescribe off-label, so the approval basis differs by drug and by route of administration rather than applying to the whole drug class at once. Which medication is appropriate, at what dose, and in what form is a decision for the provider who evaluates you, based on your health history rather than on what you arrived intending to ask for.
Source: FDA-approved label, Wegovy® (semaglutide) injection, NDA 215256, June 2021, on the chronic weight management indication referenced above.
Not sure whether you meet the criteria?
This tool compares what you enter against published FDA labeling criteria, entirely in your browser. The full criteria table, with a source on every row, is on our eligibility criteria page.
Check the published criteria against your details
Everything you enter stays in your browser. Nothing is sent anywhere, saved, or shared. This tool shows what published FDA labeling criteria describe. It is not a diagnosis, and it is not a recommendation. A licensed provider makes the actual determination.